6d7d4681373e2fd6027b9f5b24357c76  pmc_31512258.pdf
9b00600f8c0f0395280b6fc987d363cf43bb120f  pmc_31512258.pdf
d4446f39b86023000a6b38eced2a0ed60a95b8baf1f3d094450d5b75dd5b9a5e  pmc_31512258.pdf

Title:          Final analysis from RESONATE: up to 6 years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma
Creator:        Arbortext Advanced Print Publisher 9.1.520/W Unicode
Producer:       Acrobat Distiller 8.0.0 (Windows)
CreationDate:   Fri Nov 15 11:44:54 2019 CET
ModDate:        Fri Nov 15 11:44:54 2019 CET
Tagged:         no
UserProperties: no
Suspects:       no
Form:           none
JavaScript:     no
Pages:          11
Encrypted:      no
Page size:      595.276 x 782.362 pts
Page rot:       0
File size:      1904989 bytes
Optimized:      yes
PDF version:    1.7

name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
GGGHBH+AdvTTfac587ca.B               Type 1C           WinAnsi          yes yes no     259  0
GGGHBI+AdvTT6071803a.B               Type 1C           WinAnsi          yes yes no     260  0
GGGHOE+AdvTTa9c1b374                 Type 1C           WinAnsi          yes yes no     261  0
GGGKKE+AdvTTeb5f0e55.I               Type 1C           WinAnsi          yes yes no     262  0
GGGKKF+AdvTTa9c1b374+20              Type 1C           WinAnsi          yes yes no     263  0
GGGKLG+AdvTTf9cab861                 Type 1C           WinAnsi          yes yes no     264  0
GGGKOG+AdvTTa9c1b374+02              Type 1C           Custom           yes yes yes    113  0
GGGKOH+AdvTTa9c1b374+22              Type 1C           Custom           yes yes yes    114  0
GGGLOC+AdvOT8608a8d1+22              Type 1C           Custom           yes yes no      16  0
GGGNNH+HelveticaLTStd-Roman          Type 1C           Custom           yes yes yes    117  0
GGGNOH+HelveticaLTStd-Bold           Type 1C           WinAnsi          yes yes no     118  0
GGGOMD+HelveticaLTStd-Obl            Type 1C           WinAnsi          yes yes no     115  0
GGGOPD+AdvOT8608a8d1                 Type 1C           WinAnsi          yes yes no     116  0
GGHBFF+AdvTTa9c1b374+21              Type 1C           WinAnsi          yes yes no      45  0
GGHCGA+ArialMT                       Type 1C           WinAnsi          yes yes no      55  0
GGHCHB+Arial-BoldMT                  Type 1C           WinAnsi          yes yes no      56  0

Jhove (Rel. 1.22.1, 2019-04-17)
 Date: 2020-08-10 12:28:31 CEST
 RepresentationInformation: pmc_31512258.pdf
  ReportingModule: PDF-hul, Rel. 1.12.1 (2019-04-17)
  LastModified: 2020-03-02 03:58:15 CET
  Size: 1904989
  Format: PDF
  Version: 1.7
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 280
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    PageLayout: SinglePage
    PageMode: UseNone
    Outlines: 
     Item: 
      Title: Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphoc...
      Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@63440df3
      Children: 
       Item: 
        Title: 1  INTRODUCTION
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@3aeaafa6
       Item: 
        Title: 2  METHODS
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@76a3e297
        Children: 
         Item: 
          Title: 2.1  Patients
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@4d3167f4
         Item: 
          Title: 2.2  Study Design
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@ed9d034
         Item: 
          Title: 2.3  Assessments
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@6121c9d6
         Item: 
          Title: 2.4  Statistical methods
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@87f383f
         Item: 
          Title: 2.5  Data sharing statement
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@4eb7f003
       Item: 
        Title: 3  RESULTS
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@eafc191
        Children: 
         Item: 
          Title: 3.1  Patient features
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@612fc6eb
         Item: 
          Title: 3.2  Progression-free survival
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@1060b431
         Item: 
          Title: 3.3  Overall response
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@612679d6
         Item: 
          Title: 3.4  Overall survival
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@11758f2a
         Item: 
          Title: 3.5  Patient-reported outcomes
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@e720b71
         Item: 
          Title: 3.6  Adverse events
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@1b26f7b2
         Item: 
          Title: 3.7  Response to next-line treatment following ibrutinib discontinuation
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@491cc5c9
       Item: 
        Title: 4  DISCUSSION
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@74ad1f1f
       Item: 
        Title: ACKNOWLEDGMENTS
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@6a1aab78
       Item: 
        Title:   CONFLICT OF INTEREST
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@462d5aee
       Item: 
        Title:   AUTHORSHIP CONTRIBUTIONS
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@69b0fd6f
       Item: 
        Title: REFERENCES
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@757942a1
   Info: 
    Title: Final analysis from RESONATE: up to 6 years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma
    Creator: Arbortext Advanced Print Publisher 9.1.520/W Unicode
    Producer: Acrobat Distiller 8.0.0 (Windows)
    CreationDate: Fri Nov 15 12:14:54 CET 2019
    ModDate: Fri Nov 15 12:14:54 CET 2019
   ID: 0x077867a0b7eb181d06a5b183fa27135c, 0x9d7ba2d24552ec7633986480f7c2f86e
   Filters: 
    FilterPipeline: FlateDecode
   Fonts: 
    Type1: 
     Font: 
      BaseFont: GGGHBH+AdvTTfac587ca.B
      FontSubset: true
      FirstChar: 49
      LastChar: 85
      FontDescriptor: 
       FontName: GGGHBH+AdvTTfac587ca.B
       Flags: Nonsymbolic
       FontBBox: -72, -177, 1062, 958
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GGGHBI+AdvTT6071803a.B
      FontSubset: true
      FirstChar: 37
      LastChar: 124
      FontDescriptor: 
       FontName: GGGHBI+AdvTT6071803a.B
       Flags: Nonsymbolic
       FontBBox: -52, -177, 1041, 947
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GGGHOE+AdvTTa9c1b374
      FontSubset: true
      FirstChar: 37
      LastChar: 246
      FontDescriptor: 
       FontName: GGGHOE+AdvTTa9c1b374
       Flags: Nonsymbolic
       FontBBox: -41, -177, 1010, 927
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GGGKKE+AdvTTeb5f0e55.I
      FontSubset: true
      FirstChar: 39
      LastChar: 121
      FontDescriptor: 
       FontName: GGGKKE+AdvTTeb5f0e55.I
       Flags: Nonsymbolic
       FontBBox: -83, -177, 989, 927
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GGGKKF+AdvTTa9c1b374+20
      FontSubset: true
      FirstChar: 147
      LastChar: 150
      FontDescriptor: 
       FontName: GGGKKF+AdvTTa9c1b374+20
       Flags: Nonsymbolic
       FontBBox: -239, -218, 1166, 937
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GGGKLG+AdvTTf9cab861
      FontSubset: true
      FirstChar: 48
      LastChar: 57
      FontDescriptor: 
       FontName: GGGKLG+AdvTTf9cab861
       Flags: Nonsymbolic
       FontBBox: -41, -177, 1031, 937
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GGHBFF+AdvTTa9c1b374+21
      FontSubset: true
      FirstChar: 153
      LastChar: 153
      FontDescriptor: 
       FontName: GGHBFF+AdvTTa9c1b374+21
       Flags: Nonsymbolic
       FontBBox: 0, -166, 1104, 770
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GGGLOC+AdvOT8608a8d1+22
      FontSubset: true
      FirstChar: 21
      LastChar: 21
      FontDescriptor: 
       FontName: GGGLOC+AdvOT8608a8d1+22
       Flags: Nonsymbolic
       FontBBox: 0, -322, 1218, 968
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: GGGKOG+AdvTTa9c1b374+02
      FontSubset: true
      FirstChar: 1
      LastChar: 3
      FontDescriptor: 
       FontName: GGGKOG+AdvTTa9c1b374+02
       Flags: Symbolic
       FontBBox: -104, -250, 1000, 989
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: GGGKOH+AdvTTa9c1b374+22
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: GGGKOH+AdvTTa9c1b374+22
       Flags: Symbolic
       FontBBox: 0, -166, 677, 854
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: GGGOMD+HelveticaLTStd-Obl
      FontSubset: true
      FirstChar: 32
      LastChar: 86
      FontDescriptor: 
       FontName: GGGOMD+HelveticaLTStd-Obl
       Flags: Nonsymbolic, Italic
       FontBBox: -170, -225, 1116, 931
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GGGOPD+AdvOT8608a8d1
      FontSubset: true
      FirstChar: 42
      LastChar: 42
      FontDescriptor: 
       FontName: GGGOPD+AdvOT8608a8d1
       Flags: Nonsymbolic
       FontBBox: -62, -208, 927, 958
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GGGNNH+HelveticaLTStd-Roman
      FontSubset: true
      FirstChar: 2
      LastChar: 223
      FontDescriptor: 
       FontName: GGGNNH+HelveticaLTStd-Roman
       Flags: Symbolic
       FontBBox: -166, -225, 1000, 931
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: GGGNOH+HelveticaLTStd-Bold
      FontSubset: true
      FirstChar: 32
      LastChar: 122
      FontDescriptor: 
       FontName: GGGNOH+HelveticaLTStd-Bold
       Flags: Nonsymbolic, ForceBold
       FontBBox: -170, -228, 1003, 962
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GGHCGA+ArialMT
      FontSubset: true
      FirstChar: 32
      LastChar: 121
      FontDescriptor: 
       FontName: GGHCGA+ArialMT
       Flags: Nonsymbolic
       FontBBox: -665, -325, 2000, 1040
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: GGHCHB+Arial-BoldMT
      FontSubset: true
      FirstChar: 32
      LastChar: 116
      FontDescriptor: 
       FontName: GGHCHB+Arial-BoldMT
       Flags: Nonsymbolic
       FontBBox: -628, -376, 2000, 1056
       FontFile3: true
      Encoding: WinAnsiEncoding
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 5.4-c005 78.147326, 2012/08/23-13:03:03 ">
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
<rdf:Description rdf:about=""
xmlns:xmp="http://ns.adobe.com/xap/1.0/"
xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
xmlns:pdfx="http://ns.adobe.com/pdfx/1.3/"
xmlns:jav="http://www.niso.org/schemas/jav/1.0/" 
xmlns:prism="http://prismstandard.org/namespaces/basic/3.0/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/">
<jav:journal_article_version>VoR</jav:journal_article_version>
<prism:doi>10.1002/ajh.25638</prism:doi>
<pdfx:WPS-ARTICLEDOI>10.1002/ajh.25638</pdfx:WPS-ARTICLEDOI>
<pdfx:WPS-JOURNALDOI>10.1002/(ISSN)1096-8652</pdfx:WPS-JOURNALDOI>
<pdfx:WPS-PROCLEVEL>3</pdfx:WPS-PROCLEVEL> 
<dc:title>
<rdf:Alt>
<rdf:li xml:lang="x-default">Final analysis from RESONATE: up to 6 years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma</rdf:li>
</rdf:Alt>
</dc:title>
</rdf:Description>
</rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 116, 575, 124, 584
      Annotation: 
       Subtype: Link
       Rect: 353, 575, 362, 584
      Annotation: 
       Subtype: Link
       Rect: 487, 535, 495, 544
      Annotation: 
       Subtype: Link
       Rect: 64, 184, 113, 191
      Annotation: 
       Subtype: Link
       Rect: 93, 80, 134, 86
      Annotation: 
       Subtype: Link
       Rect: 204, 61, 381, 68
      Annotation: 
       Subtype: Link
       Rect: 413, 25, 517, 32
     Thumb: true
    Page: 
     Label: 2
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 366, 519, 447, 528
      Annotation: 
       Subtype: Link
       Rect: 343, 61, 398, 69
     Thumb: true
    Page: 
     Label: 3
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 44, 564, 99, 572
      Annotation: 
       Subtype: Link
       Rect: 246, 61, 287, 69
      Annotation: 
       Subtype: Link
       Rect: 44, 48, 72, 56
     Thumb: true
    Page: 
     Label: 4
     Thumb: true
    Page: 
     Label: 5
     Thumb: true
    Page: 
     Label: 6
     Thumb: true
    Page: 
     Label: 7
     Thumb: true
    Page: 
     Label: 8
     Thumb: true
    Page: 
     Label: 9
     Thumb: true
    Page: 
     Label: 10
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 88, 490, 96, 498
      Annotation: 
       Subtype: Link
       Rect: 98, 488, 241, 496
      Annotation: 
       Subtype: Link
       Rect: 94, 476, 102, 485
      Annotation: 
       Subtype: Link
       Rect: 104, 475, 247, 483
      Annotation: 
       Subtype: Link
       Rect: 93, 463, 101, 471
      Annotation: 
       Subtype: Link
       Rect: 103, 461, 246, 469
      Annotation: 
       Subtype: Link
       Rect: 486, 52, 550, 60
     Thumb: true
    Page: 
     Label: 11
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 60, 724, 283, 732
      Annotation: 
       Subtype: Link
       Rect: 60, 714, 226, 721
      Annotation: 
       Subtype: Link
       Rect: 106, 598, 232, 606
      Annotation: 
       Subtype: Link
       Rect: 495, 541, 523, 549
      Annotation: 
       Subtype: Link
       Rect: 319, 528, 416, 536
     Thumb: true
  Checksum: 63285ec8
   Type: CRC32
  Checksum: 6d7d4681373e2fd6027b9f5b24357c76
   Type: MD5
  Checksum: 9b00600f8c0f0395280b6fc987d363cf43bb120f
   Type: SHA-1